US FDA to convene expert panel to review wider access to some peptides Reuters RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Ars Technica Orthopedic Use of BPC 157 Sports Med Review The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York